Considering the important advances in treating specific types of systemic amyloidoses, unequivocal typing of amyloid deposits is now essential. Subcutaneous abdominal fat aspiration is the easiest, most common diagnostic procedure. We developed a novel, automated approach, based on Multidimensional Protein Identification Technology (MudPIT), for typing amyloidosis.
Introduction
Multiple unrelated autologous proteins can cause systemic amyloidoses 1, 2 . Due to the frequent unreliability of traditional, histochemistry-based typing techniques [4] [5] [6] , novel proteomic strategies, based on mass spectrometry (MS) identification of the protein constituents of the deposits, have been proposed 7, 8 . Multidimensional Protein Identification Technology (MudPIT) 9, 10 is an automated, highthroughput proteomic approach that allows identifying hundreds of proteins in complex samples.
We used MudPIT profiling for typing amyloid deposits in whole, non-fixed subcutaneous fat aspirates from patients affected by the most common forms of systemic amyloidoses: ALλ, ALκ, ATTR and reactive (AA) amyloidosis. A simple diagnostic algorithm -α -value -was developed to use proteomic data for precise amyloid type assignment.
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Methods
Subcutaneous abdominal fat was obtained by fine needle aspiration from 26 systemic amyloidosis patients (12 ALλ, 4 ALκ, 5 ATTR, 5 AA) and 11 non-affected controls (Tables 1A,   1S ; Supplemental Material). Sample weight ranged between 10 and 20 mg both in patients (median 12 mg) and controls (median 15 mg). The use of the tissue for research purposes was approved by the Ethical Committee of Fondazione IRCCS Policlinico San Matteo, Pavia. All individuals gave written informed consent in accordance with the Declaration of Helsinki for storing and using their biological samples for research purposes, according to the IRB guidelines.
Specific amyloidosis type was confirmed by immuno-electron microscopy (IEM), a reference method developed at our center 11 . All patients' samples had Congo red (CR) positivity score 15 . Further details in Supplemental Methods.
Results and Discussion
MudPIT allowed identifying hundreds of proteins in each fat sample, among which a few carriedover serum proteins (Supplemental Table 2S ). Protein profiles from amyloidosis patients were compared against that of the control counterpart; this allowed minimizing the contribution of contaminating blood proteins and selecting up-represented proteins in patients. (Tables 1B, 3S ). Additionally, other proteins (Table 3S ) were found to be over-represented across the various amyloidoses, including clusterin 16 , apolipoprotein E 17, 18 , apolipoprotein A-IV 19 , vitronectin 17 , basement membrane-specific heparan sulfate proteoglycan core protein 20 , sushirepeat-containing protein (SRPX), serum amyloid P 21 . Most of these had previously been α -value allows to estimate the abundance of each amyloid protein relative to the remaining ones, eliminating the confounding effect of carried-over LC, SAA and TTR from blood (Table 1B) . The diagnostic capability of the algorithm was tested by assigning in blind the amyloid type to the above described patients. The indicate this method as a specific and informative novel potential diagnostic approach, granting its application on larger, independent patients sets, possibly through a multicenter collaboration.
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